PCN265 TARGETED REVIEW OF ADVERSE EVENTS ASSOCIATED WITH TREATMENTS FOR STAGE 3 AND 4 MELANOMA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.460
https://www.valueinhealthjournal.com/article/S1098-3015(19)32838-4/fulltext
Title :
PCN265 TARGETED REVIEW OF ADVERSE EVENTS ASSOCIATED WITH TREATMENTS FOR STAGE 3 AND 4 MELANOMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32838-4&doi=10.1016/j.jval.2019.09.460
First page :
Section Title :
Open access? :
No
Section Order :
10385